These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 35578248)
21. Synaptic vesicle glycoprotein 2A (SV2A) levels in the cerebral cortex in patients with Alzheimer's disease: a radioligand binding study in postmortem brains. Mikkelsen JD; Kaad S; Aripaka SS; Finsen B Neurobiol Aging; 2023 Sep; 129():50-57. PubMed ID: 37269646 [TBL] [Abstract][Full Text] [Related]
22. Expression of SV2 isoforms during rodent brain development. Crèvecœur J; Foerch P; Doupagne M; Thielen C; Vandenplas C; Moonen G; Deprez M; Rogister B BMC Neurosci; 2013 Aug; 14():87. PubMed ID: 23937191 [TBL] [Abstract][Full Text] [Related]
23. Altered balance between excitatory and inhibitory inputs onto CA1 pyramidal neurons from SV2A-deficient but not SV2B-deficient mice. Venkatesan K; Alix P; Marquet A; Doupagne M; Niespodziany I; Rogister B; Seutin V J Neurosci Res; 2012 Dec; 90(12):2317-27. PubMed ID: 22847229 [TBL] [Abstract][Full Text] [Related]
24. SV2 is the protein receptor for botulinum neurotoxin A. Dong M; Yeh F; Tepp WH; Dean C; Johnson EA; Janz R; Chapman ER Science; 2006 Apr; 312(5773):592-6. PubMed ID: 16543415 [TBL] [Abstract][Full Text] [Related]
26. Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons. Dong M; Liu H; Tepp WH; Johnson EA; Janz R; Chapman ER Mol Biol Cell; 2008 Dec; 19(12):5226-37. PubMed ID: 18815274 [TBL] [Abstract][Full Text] [Related]
27. SV2A and SV2C are not vesicular Ca2+ transporters but control glucose-evoked granule recruitment. Iezzi M; Theander S; Janz R; Loze C; Wollheim CB J Cell Sci; 2005 Dec; 118(Pt 23):5647-60. PubMed ID: 16306227 [TBL] [Abstract][Full Text] [Related]
31. Distribution of SV2C mRNA and protein expression in the mouse brain with a particular emphasis on the basal ganglia system. Dardou D; Dassesse D; Cuvelier L; Deprez T; De Ryck M; Schiffmann SN Brain Res; 2011 Jan; 1367():130-45. PubMed ID: 20869353 [TBL] [Abstract][Full Text] [Related]
32. Spatio-Temporal Alterations in Synaptic Density During Epileptogenesis in the Rat Brain. Mikkelsen JD; Aripaka SS; Bascuñana P; Bankstahl M; Bankstahl JP; Pazarlar BA Neuroscience; 2022 Sep; 499():142-151. PubMed ID: 35878719 [TBL] [Abstract][Full Text] [Related]
33. In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C]UCB-J PET. Thomsen MB; Jacobsen J; Lillethorup TP; Schacht AC; Simonsen M; Romero-Ramos M; Brooks DJ; Landau AM J Cereb Blood Flow Metab; 2021 Apr; 41(4):819-830. PubMed ID: 32538280 [TBL] [Abstract][Full Text] [Related]
34. SV2 mediates entry of tetanus neurotoxin into central neurons. Yeh FL; Dong M; Yao J; Tepp WH; Lin G; Johnson EA; Chapman ER PLoS Pathog; 2010 Nov; 6(11):e1001207. PubMed ID: 21124874 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain. Nabulsi NB; Mercier J; Holden D; Carré S; Najafzadeh S; Vandergeten MC; Lin SF; Deo A; Price N; Wood M; Lara-Jaime T; Montel F; Laruelle M; Carson RE; Hannestad J; Huang Y J Nucl Med; 2016 May; 57(5):777-84. PubMed ID: 26848175 [TBL] [Abstract][Full Text] [Related]
36. Tracing synaptic loss in Alzheimer's brain with SV2A PET-tracer UCB-J. Kumar A; Scarpa M; Nordberg A Alzheimers Dement; 2024 Apr; 20(4):2589-2605. PubMed ID: 38363009 [TBL] [Abstract][Full Text] [Related]
37. Synaptic vesicle protein SV2B, but not SV2A, is predominantly expressed and associated with microvesicles in rat pinealocytes. Hayashi M; Yamamoto A; Yatsushiro S; Yamada H; Futai M; Yamaguchi A; Moriyama Y J Neurochem; 1998 Jul; 71(1):356-65. PubMed ID: 9648885 [TBL] [Abstract][Full Text] [Related]
38. Development and In Vivo Preclinical Imaging of Fluorine-18-Labeled Synaptic Vesicle Protein 2A (SV2A) PET Tracers. Constantinescu CC; Tresse C; Zheng M; Gouasmat A; Carroll VM; Mistico L; Alagille D; Sandiego CM; Papin C; Marek K; Seibyl JP; Tamagnan GD; Barret O Mol Imaging Biol; 2019 Jun; 21(3):509-518. PubMed ID: 30084043 [TBL] [Abstract][Full Text] [Related]
39. Autoradiographic mapping of synaptic vesicle glycoprotein 2A in non-human primate and human brain. Varnäs K; Stepanov V; Halldin C Synapse; 2020 Oct; 74(10):e22157. PubMed ID: 32259300 [TBL] [Abstract][Full Text] [Related]
40. Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease. Dunn AR; Stout KA; Ozawa M; Lohr KM; Hoffman CA; Bernstein AI; Li Y; Wang M; Sgobio C; Sastry N; Cai H; Caudle WM; Miller GW Proc Natl Acad Sci U S A; 2017 Mar; 114(11):E2253-E2262. PubMed ID: 28246328 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]